← Back to KTTAReportPortrait · background graphics on

SPZCOPasithea Therapeutics Corp. · KTTAData at close 2026-08-19

Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1841330 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD)

Last $0.49Day −1.53%Mkt cap $17M1Y −31.2%Off 52W high −76.2%Vol (1Y) 156.1%

Price2023-08-21 → 2026-08-19

KTTA close: $11.9 on 2023-08-21 to $0.5 on 2026-08-19.

Split-adj closes · 240 of 1,233 · price return

At a glance

Short interest0.6% of sh out

Days to cover1.0d

13F net flow (QoQ)+2.26%

Top-10 13F concentration97.7%

Next report (est.)2026-11-13

SI 2026-07-31 · 13F 2026-Q1

Key fundamentalsFY 2025

Sales (TTM)$486,559

Earnings (TTM)-$21.3M

ROE−58.4%

FY ratios · TTM sales/earnings (USD)

Trailing returns

YTD−62.0%

1Y−31.2%

3Y−95.9%

Since incept. (ann.)−63.2%

Total return · from 2021-09-16

Risk

Ann. volatility (1Y)156.1%

Ann. volatility (3Y)129.2%

Sharpe (1Y)0.34

Sharpe (3Y)−0.29

Max drawdown (1Y)−69.8%

Max drawdown (3Y)−97.6%

Beta (3Y vs SPY)−0.11

Daily returns, ann.

Top institutional holders13F 2026-Q1

Manager	Shares	Value	% sh out	QoQ
JANUS HENDERSON GROUP PLC	2.1M	$2M	8.42%	+0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.	2.1M	$2M	8.42%	+0.0%
Vivo Capital, LLC	2.1M	$2M	8.42%	+0.0%
Squadron Capital Management LLC	2.1M	$2M	8.42%	+0.0%
AMERIPRISE FINANCIAL INC	1.4M	$1M	5.42%	−30.0%
Cable Car Capital, LP	1.2M	$894,892	4.84%	+141.3%
Stonepine Capital Management, LLC	831,301	$616,659	3.33%	+202.2%
AdvisorShares Investments LLC	337,508	$250,363	1.35%	+10.8%

Δ vs 2025-Q4

Latest reported quarterslast report 2026-08-14

Period end	Reported	EPS	EPS YoY	Revenue	Rev YoY
2026-06-30	2026-08-14	−$0.16	—	—	—
2026-03-31	2026-05-15	−$0.12	—	—	—
2025-09-30	2025-11-13	−$0.41	—	—	—
2025-06-30	2025-08-14	−$0.66	—	—	—

As-reported XBRL · next 2026-11-13 est.

Basis & disclosures